Daily news email for March 09, 2010 | Click here for updated news
BioSpace
Compugen Ltd. Appoints as President and CEO
U.S. FDA Panel Backs Bristol-Myers Squibb Company Transplant Drug
Watson Pharmaceuticals, Inc. To Sell ScinoPharm Taiwan Stake For $94 Million
Private UK Drug Firm Archimedes Pharma Raises $97 Million; Former Enzon Pharmaceuticals, Inc. Head Appointed as CEO; US Commercial Operations to be Established
Astellas Pharma Inc. Commences Tender Offer to Acquire All Outstanding Shares of OSI Pharmaceuticals, Inc. for $52 per Share in Cash; Bid Goes Hostile
|
BioSpace - Breaking News
Odyssey Thera, Inc. Announces Agreement with Lonza Inc.
Pressure BioSciences, Inc. and Target Discovery, Inc. Announce Product Licensing, Manufacturing, Co-Marketing, and Collaborative R&D Agreement
BioSpecifics Technologies Corporation Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
Exelixis, Inc. Announces Restructuring; Reduces Workforce by Approximately 40%, or 270 Employees
Trading Halted Today in InterMune, Inc. Common Stock; FDA Advisory Committee Reviewing Pirfenidone Data in Idiopathic Pulmonary Fibrosis
|
Biotech News - Business Wire
Venn Life Sciences Appoints New VP Business Development
William A. Hawkins, Medtronic Chairman and CEO, Receives Distinguished Achievement Award from Biomedical Engineering Society
Rosetta Genomics to Present at the 22nd Annual Roth OC Growth Stock Conference
biospace med Signs Distribution Agreement with Odelft for Benelux
BioMimetic Therapeutics Presents Promising Pre-Clinical Sports Medicine Data at the 2010 ORS Meeting
|
FDA Drugs- What's New
Non-Inferiority Clinical Trials
Submission of Documentation in Applications for Parametric Release of Human and Veterinary Drug Products Terminally Sterilized by Moist Heat Processes
FDA Drug Safety Communication: Ongoing safety review of Invirase (saquinavir) and possible association with abnormal heart rhythms
FDA Drug Safety Communication: Ongoing review of Avandia (rosiglitazone) and cardiovascular safety
Potential Signals of Serious Risks/New Safety Information Identified from the Adverse Event Reporting System (AERS) between July - September 2009
|
FDA News - Business Wire
Morinaga Milk Industry Co., Ltd. Receives No Objection Letter from FDA Regarding GRAS Status of Proprietary Probiotic Strain, Bifidobacterium longum BB536
Ischemix Initiates Phase 2a Trial of CMX-2043 for the Prevention of Ischemia-Reperfusion Injury
Expert Consortium Launches Chemistry Playbook®, Expedited CMC Solutions From Cambridge Major Laboratories, Xcelience, Beckloff Associates, and Avantium Pharma
Biologics Consulting Group, Inc. Announces Stephen P. Rhodes as Senior Consultant, Expands Expertise in Medical Devices and Combination Products
Investigation Relating to the Labeling of Sunsweet Antioxidant Blend Dried Fruit Mixes Announced by Stember Feinstein Doyle & Payne, LLC
|
FDA Press Releases
FDA Update on the Investigation into the Salmonella Montevideo Outbreak - March 5, 2010
FDA Investigation Reveals Salmonella Tennessee at Plant that Makes Flavor Enhancers for Food Processors and Other Distributors
La FDA advierte a los consumidores en Puerto Rico acerca de la presencia de una bacteria dañina en desinfectantes para manos
La FDA advierte a los consumidores en Puerto Rico acerca de la presencia de una bacteria dañina en desinfectantes para manos
FDA Warns Consumers in Puerto Rico of Harmful Bacteria in Hand Sanitizers
|
